Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 57,982 | 83,602 | 7,350 | 38,635 | 117,764 |
| Marketable Securities | N/A | N/A | N/A | 20,534 | N/A |
| Receivables | N/A | 2,336 | N/A | 11,043 | 3,313 |
| TOTAL | $58,987 | $88,234 | $7,548 | $73,424 | $127,625 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 16,992 | 19,122 |
| Other Non-Current Assets | 572 | 0 | 0 | 5,074 | 6,813 |
| TOTAL | $572 | $N/A | $N/A | $22,066 | $25,935 |
| Total Assets | $59,559 | $88,234 | $7,548 | $95,490 | $153,560 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,595 | 4,586 | 936 | 4,154 | 8,609 |
| Accrued Expenses | 4,351 | 5,474 | 1,424 | 10,746 | 16,836 |
| Other current liabilities | 2,196 | 1,978 | N/A | N/A | N/A |
| TOTAL | $11,344 | $12,038 | $2,360 | $36,583 | $50,561 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 20,824 | 25,116 |
| Other Non-Current Liabilities | 20,232 | 13,589 | 9,068 | 12,244 | 13,841 |
| TOTAL | $20,232 | $13,589 | $9,068 | $30,978 | $52,244 |
| Total Liabilities | $31,576 | $25,627 | $11,428 | $67,561 | $102,805 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,314 | 11,019 | 1,237 | 931 | 926 |
| Common Shares | 12 | 11 | N/A | 74 | 72 |
| Retained earnings | -135,450 | -93,735 | -76,301 | -290,421 | -257,144 |
| Other shareholders' equity | 83 | 3 | 70,603 | -254 | 829 |
| TOTAL | $27,983 | $62,607 | $-3,880 | $27,929 | $50,755 |
| Total Liabilities And Equity | $59,559 | $88,234 | $7,548 | $95,490 | $153,560 |